Amir Khodavirdipour1,2, Motahareh Piri3, Sarvin Jabbari1, Shiva Keshavarzi3, Reza Safaralizadeh1, Mohammad Yousef Alikhani4. 1. Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran. 2. Division of Human Genetics, Department of Anatomy, St. John's Hospital, Bangalore, India. 3. Department of Biology, Faculty of Basic Sciences, University of Zabol, Zabol, Iran. 4. Department of Medical Microbiology, Hamedan University of Medical Sciences, Hamedan, Iran. alikhani@umsha.ac.ir.
Abstract
INTRODUCTION: Interruption of regulation of apoptosis can play a leading role in cancers where elevated apoptosis causes neurodegeneration, autoimmunity, AIDS, and ischemia. One famous example can be p53's downregulation, which is a tumor suppressor gene, which consequently can cause a decrease in apoptosis rate and intense tumor growth and progression and development and inactivation of 53; it can be extended to many cancers in human. Anyhow, apoptosis is a double-edge sword. There are many trials and studies are going on observation and understanding of different steps involved in apoptosis. Apoptosis has a very major role in carcinogenesis and the treatment of cancer. AIM: In this updated-cum-comprehensive review, we would like to cover what is apoptosis and cancer and also, will discuss all known methods of apoptosisdetection, their applicability in the treatment of cancer, and their advantages, disadvantages, and limitations. MATERIAL AND METHODS: Published articles on indexing sources such as PubMed, Scopus from 2000 to date. RESULT: By considering all above information including each methods pros and cons, these routine methods could be great tool with distinctive qualities in treatmentwhich can be great help from patient perspective and as well from government ad health care system point of view. CONCLUSION: Accurate diagnosis of cell apoptotic biopathways at different stages assists in evaluating near to exact apoptotic index, which is the perfect sign andindicator for metastasis and also prognosis, thus foreseeing treatment outcome.
INTRODUCTION: Interruption of regulation of apoptosis can play a leading role in cancers where elevated apoptosis causes neurodegeneration, autoimmunity, AIDS, and ischemia. One famous example can be p53's downregulation, which is a tumor suppressor gene, which consequently can cause a decrease in apoptosis rate and intense tumor growth and progression and development and inactivation of 53; it can be extended to many cancers in human. Anyhow, apoptosis is a double-edge sword. There are many trials and studies are going on observation and understanding of different steps involved in apoptosis. Apoptosis has a very major role in carcinogenesis and the treatment of cancer. AIM: In this updated-cum-comprehensive review, we would like to cover what is apoptosis and cancer and also, will discuss all known methods of apoptosisdetection, their applicability in the treatment of cancer, and their advantages, disadvantages, and limitations. MATERIAL AND METHODS: Published articles on indexing sources such as PubMed, Scopus from 2000 to date. RESULT: By considering all above information including each methods pros and cons, these routine methods could be great tool with distinctive qualities in treatmentwhich can be great help from patient perspective and as well from government ad health care system point of view. CONCLUSION: Accurate diagnosis of cell apoptotic biopathways at different stages assists in evaluating near to exact apoptotic index, which is the perfect sign andindicator for metastasis and also prognosis, thus foreseeing treatment outcome.
Entities:
Keywords:
Apoptosis; Apoptosis detection methods; Cancer treatment; Caspase; Flow cytometry; TEM
Authors: J A Roth; D Nguyen; D D Lawrence; B L Kemp; C H Carrasco; D Z Ferson; W K Hong; R Komaki; J J Lee; J C Nesbitt; K M Pisters; J B Putnam; R Schea; D M Shin; G L Walsh; M M Dolormente; C I Han; F D Martin; N Yen; K Xu; L C Stephens; T J McDonnell; T Mukhopadhyay; D Cai Journal: Nat Med Date: 1996-09 Impact factor: 53.440
Authors: Thomas M Rippin; Vladimir J N Bykov; Stefan M V Freund; Galina Selivanova; Klas G Wiman; Alan R Fersht Journal: Oncogene Date: 2002-03-28 Impact factor: 9.867
Authors: J Kuball; M Schuler; E Antunes Ferreira; W Herr; M Neumann; L Obenauer-Kutner; L Westreich; C Huber; T Wölfel; M Theobald Journal: Gene Ther Date: 2002-07 Impact factor: 5.250
Authors: Frank M Boeckler; Andreas C Joerger; Gaurav Jaggi; Trevor J Rutherford; Dmitry B Veprintsev; Alan R Fersht Journal: Proc Natl Acad Sci U S A Date: 2008-07-23 Impact factor: 11.205
Authors: Inge Marie Svane; Anders E Pedersen; Hans E Johnsen; Dorte Nielsen; Claus Kamby; Eva Gaarsdal; Kirsten Nikolajsen; Søren Buus; Mogens H Claesson Journal: Cancer Immunol Immunother Date: 2004-02-25 Impact factor: 6.968